We are live on ! Find out more
OXFD

Oxford Immunotec Global PLC Ordinary Shares
OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

Back to rankings

58 hedge funds and large institutions have $192M invested in Oxford Immunotec Global PLC Ordinary Shares in 2014 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 3

108% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 12

23% more funds holding

Funds holding: 47 → 58 (+11)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

6% less capital invested

Capital invested by funds: $205M → $192M (-$13.1M)

Holders
58
Holders Change
+11
Holders Change %
+23.4%
% of All Funds
1.67%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
15
Increased
25
Reduced
12
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$6.05M
2
DCC
Dow Chemical Company
Michigan
+$4.96M
3
CAM
Cortina Asset Management
Wisconsin
+$3.55M
4
Wells Fargo
Wells Fargo
California
+$3.31M
5
O
OppenheimerFunds
New York
+$2.94M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.62M
2
TCM
Tamarack Capital Management
California
-$3.36M
3
BA
BlackRock Advisors
Delaware
-$2.75M
4
BG
BlackRock Group
United Kingdom
-$1.73M
5
NCGI
Next Century Growth Investors
Minnesota
-$740K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$1.21M -$366K -20,323 -22%
Northern Trust
27
Northern Trust
Illinois
$1.04M -$57.2K -3,177 -5%
BIM
28
BlackRock Investment Management
Delaware
$967K -$92.7K -5,149 -8%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$953K +$385K +21,366 +61%
TCIM
30
TIAA CREF Investment Management
New York
$836K +$607K +33,697 +211%
Ameriprise
31
Ameriprise
Minnesota
$807K +$354K +19,645 +69%
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$469K – – –
FA
33
Friess Associates
Delaware
$404K +$28.8K +1,600 +7%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$399K +$225K +12,500 +112%
Vanguard Group
35
Vanguard Group
Pennsylvania
$353K +$195K +10,826 +107%
Charles Schwab
36
Charles Schwab
California
$322K +$344K +19,100 New
TA
37
Teachers Advisors
New York
$311K +$223K +12,376 +203%
CS
38
Credit Suisse
Switzerland
$281K +$301K +16,726 New
Geode Capital Management
39
Geode Capital Management
Massachusetts
$218K +$234K +12,974 New
TC
40
TFS Capital
Pennsylvania
$208K +$223K +12,372 New
MLICM
41
Metropolitan Life Insurance Company (MetLife)
New York
$181K +$194K +10,762 New
PC
42
Polar Capital
United Kingdom
$175K +$187K +10,389 New
NFA
43
Nationwide Fund Advisors
Ohio
$162K +$87.8K +4,878 +102%
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$149K +$105K +5,818 +190%
AIG
45
American International Group
New York
$143K +$77.7K +4,314 +103%
WT
46
Wellcome Trust
United Kingdom
$73K +$78.3K +4,350 New
U
47
UBS
Switzerland
$32K +$32K +1,778 +1,778%
TRCT
48
Tower Research Capital (TRC)
New York
$24K +$26.1K +1,451 New
AllianceBernstein
49
AllianceBernstein
Tennessee
$20K +$21.6K +1,200 New
VFA
50
Virtus Fund Advisers
Connecticut
$19K +$20K +1,109 New
1
2
3

OXFD Hedge Fund Activity: Q2 2014 in Review

58 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q2 2014, worth a combined $192M — down 6.4% from $205M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new OXFD positions and 3 closed out — a net gain of 12 holders — while 25 added to existing stakes and 12 trimmed.

The largest buyer was Redmile Group, adding an estimated $6.05M. The largest seller was Fidelity Investments, exiting entirely with an estimated $4.62M sold.

  • 58 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q2 2014, up from 47 in Q1 2014.
  • Funds reported $192M of Oxford Immunotec Global PLC Ordinary Shares stock for Q2 2014, down 6.4% quarter-over-quarter.
  • 15 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q2 2014 and 3 closed out, a net change of +12 holders.
  • The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q2 2014 was Redmile Group, an estimated $6.05M added.
  • The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q2 2014 was Fidelity Investments, an estimated $4.62M sold.

Based on aggregated 13F filings for Q2 2014.